Anesthesia and renal disease

Current Opinion in Anaesthesiology

Volumn 15, Issue 3, 2002, Pages 359-363

  Cróinín, Dónall F ^a   Shorten, George D ^a  

^a University College Cork and INFANT Centre   (Ireland)

Author keywords

Anesthesia; Morbidity; Outcome; Renal

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORIDE; GLUTATHIONE TRANSFERASE; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; PROPOFOL; SEVOFLURANE;

ANESTHESIA; AORTA ANEURYSM; AORTA SURGERY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; ENDOVASCULAR SURGERY; EPIDURAL ANESTHESIA; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY INJURY; NEPHROTOXICITY; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0036263745     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200206000-00014     Document Type: Review

References (50)

1. Perioperative acute renal failure
2. Anesthetic considerations for the patient with renal failure
3. Reaction of sevoflurane and its degradation products with soda lime: Toxicity of its byproducts
4. Degradation products of sevoflurane during low flow anesthesia
5. Toxicity of compound A in rats: Effect of a 3-hour administration
6. Strategies and criteria for developing new urinalysis tests
7. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity
8. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers
9. Inhalation toxicology study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats
10. Compound A: Does it matter?
11. Human kidney methoxyflurane and sevoflurane metabolism: Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity
12. Inhalational anesthetics
13. Long-duration low-flow sevoflurane and isoflurane effects on postoperative renal and hepatic function
14. The effects of low-flow sevoflurane and isoflurane anesthesia on renal function in patients with stable moderate renal insufficiency
15. Changes in plasma creatinine concentration after cardiac anesthesia with isoflurane, propofol, or sevoflurane
16. Role of renal cysteine conjugate β-lyase in the mechanism of compound A nephrotoxicity in rats
17. Role of renal cysteine conjugates β-lyase pathway in inhaled compound A nephrotoxicity
18. Effects of probenecid on renal function in surgical patients anesthetized with low-flow sevoflurane
19. Production of compound A under low flow anesthesia is affected by type of anesthetic machine
20. Mechanisms of the nephrotoxicity of non-steroidal anti-inflammatory drugs
21. Methoxyflurane nephrotoxicity: A study of dose response in man
22. Keterolac is not nephrotoxic in connection with sevoflurane anesthesia in patients undergoing breast surgery
23. The effect of keterolac and sevoflurane anesthesia on renal glomerular and tubular function
24. Urinary excretion of glutathione S transferases alpha and pi in patients with proteinuria: Reflection of the site of tubular injury
25. Urine N-acetyl-β-glucosaminidase: A marker of tubular damage?
26. Tissue kalikrein and kinins in renal disease
27. Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia
28. Urinary biomarkers monitoring for experimental fluoride nephrotoxicity
29. Inorganic fluoride kinetics and renal and hepatic function after repeated sevoflurane anesthesia
30. Serum cystatin C as a new marker for non-invasive estimation of glomerular filtration rate and as a marker for early renal impairment
31. Alpha1-microglobulin as a marker of proximal tubular damage in urinary tract infection in children
32. Effects of losartan, prazosin on renal and femoral blood flow in conscious sheep
33. Losartan increases renal blood flow during isoflurane anesthesia in sheep
34. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function
35. Preoperative inhibition of angiotensin-converting enzyme improves systemic and renal haemodynamic changes during aortic abdominal surgery
36. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery
37. Influence of chronic angiotensin converting enzyme inhibition on anesthetic induction
38. Should angiotensin II antagonists be discontinued before surgery?
39. Reduction of postoperative mortality and morbidity with epidural or spinal anesthesia: Results from overview of randomized trials
40. Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery
41. A prospective randomized study of the potential benefits of rhoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting
42. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: Results of a randomized controlled trial
43. Thoracic epidural analgesia in aortocoronary bypass surgery I: Haemodynamic effects
44. Thoracic epidural analgesia in aortocoronary bypass surgery II: Effects on the endocrine metabolic response
45. Coronary artery bypass grafting using two different anesthetic techniques III: Adrenergic responses
46. Surgical repair of aneurysms involving the supra-renal, visceral, and lower thoracic aortic segments: Early results and late outcome
47. Endovascular AAA repair attenuates the inflammatory and renal responses associated with conventional surgery
48. Perioperative management of endovascular stent graft placement for abdominal aortic aneurysm
49. Differences in renal response between endovascular and open repair of abdominal aortic aneurysms
50. An endovascular system for thoracoabdominal aortic aneurysm repair